SmdA is a Novel Cell Morphology Determinant in Staphylococcus aureus.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 04 2022
Historique:
pubmed: 1 4 2022
medline: 29 4 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Cell division and cell wall synthesis in staphylococci need to be precisely coordinated and controlled to allow the cell to multiply while maintaining its nearly spherical shape. The mechanisms ensuring correct placement of the division plane and synthesis of new cell wall have been studied intensively. However, hitherto unknown factors and proteins are likely to play key roles in this complex interplay. Here, we identified and investigated a protein with a major influence on cell morphology in Staphylococcus aureus. The protein, named SmdA (for staphylococcal morphology determinant A), is a membrane protein with septum-enriched localization. By CRISPRi knockdown and overexpression combined with different microscopy techniques, we demonstrated that proper levels of SmdA were necessary for cell division, including septum formation and cell splitting. We also identified conserved residues in SmdA that were critical for its functionality. Pulldown and bacterial two-hybrid interaction experiments showed that SmdA interacted with several known cell division and cell wall synthesis proteins, including penicillin-binding proteins (PBPs) and EzrA. Notably, SmdA also affected susceptibility to cell wall targeting antibiotics, particularly in methicillin-resistant S. aureus (MRSA). Together, our results showed that S. aureus was dependent on balanced amounts of membrane attached SmdA to carry out proper cell division.

Identifiants

pubmed: 35357211
doi: 10.1128/mbio.03404-21
pmc: PMC9040797
doi:

Substances chimiques

Anti-Bacterial Agents 0
Penicillin-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0340421

Subventions

Organisme : Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
ID : 296906
Organisme : Norges Forskningsråd (Forskningsrådet)
ID : 250976

Références

Eur J Biochem. 1981 Oct;119(2):389-93
pubmed: 7308191
J Bacteriol. 1984 May;158(2):513-6
pubmed: 6563036
Annu Rev Microbiol. 2013;67:313-36
pubmed: 24024634
Commun Biol. 2019 Nov 15;2:417
pubmed: 31754647
PLoS Pathog. 2019 Sep 13;15(9):e1008044
pubmed: 31518377
Mol Microbiol. 2011 Jun;80(5):1366-80
pubmed: 21477126
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18909-14
pubmed: 23027967
FEMS Microbiol Rev. 2008 Mar;32(2):208-33
pubmed: 18081839
J Proteome Res. 2013 Feb 1;12(2):547-58
pubmed: 23253041
Microbiology (Reading). 2011 Mar;157(Pt 3):666-676
pubmed: 21109562
Nucleic Acids Res. 2012 Aug;40(15):7016-45
pubmed: 22638584
J Biol Chem. 2014 May 30;289(22):15680-90
pubmed: 24753256
Mol Microbiol. 2018 Sep;109(5):615-632
pubmed: 29884993
J Appl Microbiol. 2007 Mar;102(3):736-47
pubmed: 17309623
Nat Commun. 2020 Aug 14;11(1):4097
pubmed: 32796861
ACS Chem Biol. 2011 Jan 21;6(1):106-16
pubmed: 20961110
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Appl Environ Microbiol. 2004 Oct;70(10):6076-85
pubmed: 15466553
Science. 2015 May 1;348(6234):574-8
pubmed: 25931560
mBio. 2020 Jun 30;11(3):
pubmed: 32605984
Nat Commun. 2015 Aug 17;6:8055
pubmed: 26278781
Elife. 2018 Feb 21;7:
pubmed: 29465397
Antimicrob Agents Chemother. 1985 May;27(5):851-7
pubmed: 3848294
FEMS Microbiol Rev. 2008 Mar;32(2):168-207
pubmed: 18266853
Sci Transl Med. 2012 Mar 21;4(126):126ra35
pubmed: 22440737
Appl Environ Microbiol. 2004 Nov;70(11):6887-91
pubmed: 15528558
mBio. 2014 Sep 02;5(5):e01729-14
pubmed: 25182329
Annu Rev Biochem. 2018 Jun 20;87:991-1014
pubmed: 29596002
Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):285-9
pubmed: 7816834
Proteomics. 2014 May;14(9):1006-0
pubmed: 24678027
BMC Genomics. 2015 Mar 29;16:252
pubmed: 25888466
Science. 2014 Jul 11;345(6193):220-2
pubmed: 25013077
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5752-6
pubmed: 9576956
Nat Microbiol. 2019 Aug;4(8):1368-1377
pubmed: 31086309
Sci Signal. 2019 Apr 23;12(578):
pubmed: 31015289
J Antibiot (Tokyo). 2007 Aug;60(8):485-91
pubmed: 17827659
J Bacteriol. 2007 Nov;189(22):8257-69
pubmed: 17827301
J Antimicrob Chemother. 2012 Sep;67(9):2143-51
pubmed: 22615298
Nat Microbiol. 2021 Sep;6(9):1175-1187
pubmed: 34373624
Int J Antimicrob Agents. 2021 Mar;57(3):106283
pubmed: 33503451
PLoS One. 2011;6(11):e27542
pubmed: 22110668
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Appl Environ Microbiol. 2013 May;79(9):3133-6
pubmed: 23455338
Infect Immun. 2010 Jun;78(6):2877-89
pubmed: 20212089
mBio. 2016 Sep 06;7(5):
pubmed: 27601570
Antimicrob Agents Chemother. 2007 Oct;51(10):3627-33
pubmed: 17646417
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12510-5
pubmed: 25104751
J Bacteriol. 2020 Jun 1;:
pubmed: 32482719
Nat Microbiol. 2016 Jun 20;1(7):16077
pubmed: 27572972
Eur J Clin Microbiol Infect Dis. 1989 Nov;8(11):943-50
pubmed: 2532132
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18991-6
pubmed: 20944066
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31685469
Commun Biol. 2020 Nov 20;3(1):695
pubmed: 33219282
FEMS Microbiol Lett. 2006 Jun;259(2):260-8
pubmed: 16734789
Mol Microbiol. 2005 Feb;55(3):799-807
pubmed: 15661005
Curr Opin Microbiol. 2013 Oct;16(5):522-30
pubmed: 23932516
Mol Microbiol. 2011 Apr;80(2):542-55
pubmed: 21401734
Chembiochem. 2010 Jan 4;11(1):35-45
pubmed: 19899094
BMC Genomics. 2009 Jul 01;10:291
pubmed: 19570206
Antimicrob Agents Chemother. 2003 Mar;47(3):837-46
pubmed: 12604510
Sci Rep. 2018 Jan 30;8(1):1889
pubmed: 29382892
J Microbiol Methods. 2012 Sep;90(3):214-6
pubmed: 22613804
Nature. 2018 Feb 22;554(7693):528-532
pubmed: 29443967
J Bacteriol. 2009 Jan;191(1):141-51
pubmed: 18952789
BMC Microbiol. 2011 Apr 12;11:72
pubmed: 21486434
Nature. 2016 Sep 29;537(7622):634-638
pubmed: 27525505
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5959-E5968
pubmed: 28674002
Trends Biochem Sci. 2004 Mar;29(3):106-10
pubmed: 15055202
Bioinformatics. 2014 Mar 15;30(6):884-6
pubmed: 24162465
Microbiol Mol Biol Rev. 2003 Mar;67(1):52-65, table of contents
pubmed: 12626683
Nat Rev Microbiol. 2013 Sep;11(9):601-14
pubmed: 23949602
Antimicrob Agents Chemother. 2012 Apr;56(4):1810-20
pubmed: 22290958
Mol Microbiol. 2014 Mar;91(6):1088-105
pubmed: 24417389
Curr Opin Microbiol. 2013 Oct;16(5):538-48
pubmed: 23895826
mBio. 2015 May 26;6(3):e00308-15
pubmed: 26015493
J Am Chem Soc. 2018 Jan 24;140(3):876-879
pubmed: 29300473
Chem Biol. 2011 Nov 23;18(11):1379-89
pubmed: 22118672

Auteurs

Ine Storaker Myrbråten (IS)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Gro Anita Stamsås (GA)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Helena Chan (H)

Structural Cellular Biology Unit, Okinawa Institute of Science and Technology, Okinawa, Japan.
The ithree institute, University of Technology Sydneygrid.117476.2, Broadway, New South Wales, Australia.

Danae Morales Angeles (D)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Tiril Mathiesen Knutsen (TM)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Zhian Salehian (Z)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Volha Shapaval (V)

Faculty of Science and Technology, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Daniel Straume (D)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Morten Kjos (M)

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH